CytomX Therapeutics Shares Are Trading Lower, Pulling Back After Surging After Hours Thursday Following Initial Data From the Ongoing CX-904 Phase 1a Dose Escalation Clinical Study.
CytomX Therapeutics Shares Are Trading Lower, Pulling Back After Surging After Hours Thursday Following Initial Data From the Ongoing CX-904 Phase 1a Dose Escalation Clinical Study.
CytomX Therapeutics股价走低，在周四盘后飙升后回落，此前正在进行的 CX-904 1a期剂量升级临床研究得出初步数据。
CytomX Therapeutics Shares Are Trading Lower, Pulling Back After Surging After Hours Thursday Following Initial Data From the Ongoing CX-904 Phase 1a Dose Escalation Clinical Study.
CytomX Therapeutics股价走低，在周四盘后飙升后回落，此前正在进行的 CX-904 1a期剂量升级临床研究得出初步数据。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。